GXAI:NASDAQGaxos.ai Inc. Analysis
Data as of 2026-09-29 - not real-time
$0.56
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Gaxos.ai Inc. is priced at $0.5596 and its moving averages line up in bearish order, the shorter trailing the longer. Across the trailing 30 sessions it lost 34.6%. Momentum indicators put RSI at 32.1 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at $0.5130 and resistance at $0.8170.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 471.8% above the current quote. Revenue is growing at 1337.3% on a -64.8% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 56.3%, a beta of 1.17 and a maximum drawdown of 72.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 471.8% above the current quote. Revenue is growing at 1337.3% on a -64.8% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 56.3%, a beta of 1.17 and a maximum drawdown of 72.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top Market Events
Shares of Gaxos.ai Inc GXAI are trading lower Tuesday afternoon, despite the company outlining a post-divestiture...The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...Taiwan News2monGaxos Sharpens Focus to Accelerate Growth Across Revenue-Generating AI and Health and Wellness...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.13
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.13
- Analyst targets imply +471.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -64.8%
- Analyst targets imply +471.8% versus the current price
- Negative return on equity of -30.2%
Key Metrics & Analysis
Financial Health
Revenue Growth1337.30%
Profit Margin-64.79%
P/E Ratio-1.8
ROE-30.24%
ROA-26.45%
P/B Ratio0.3
Op. Cash Flow$-5420744
Free Cash Flow$-3495788
Industry P/E15.3
Technical Analysis
TrendBearish
RSI32.1
Support$0.51
Resistance$0.82
MA 20$0.66
MA 50$0.80
MA 200$1.13
MACDBearish
VolumeStable
Fear & Greed Index93.02
Valuation
Target Price$3.20
Upside/Downside471.84%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.17
Volatility56.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.